ALIVUSPharmaceuticals
Alivus Life Sciences Limited — PE Ratio & Valuation Analysis
₹972.70
-0.40%
Current P/E20.98xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E23.2x9.6% below avg
✅
34.0% Discount to Industry
ALIVUS P/E 20.98x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹39.52 | ₹917 | 23.2x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Alivus Life Sciences Limited Valuation
Alivus Life Sciences Limited (ALIVUS) currently trades at 20.98x earnings. The Pharmaceuticals sector average PE is 31.77x. ALIVUS is trading at a discount to peers — may indicate relative value. Historically, ALIVUS has traded at an average PE of 23.2x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
18.69%
Dividend Yield
0.55%
More on Alivus Life Sciences Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.